Last reviewed · How we verify

NCT03491735

Patterns of Glaucoma in Glaucoma Subspecialty Clinics in Egypt and India in the Year 2018

Status unknown Last updated 9 April 2018
What this trial tests

trial testing collection of data from patient files in Determining Patterns of Glaucoma in Glaucoma Sub-specialty Clinics in Two Countries: Egypt and India in 2,500 participants. Status unknown.

Timeline
1 January 2018
Primary endpoint
31 December 2018
31 December 2018

Quick facts

Lead sponsorKasr El Aini Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment2,500
Start date1 January 2018
Primary completion31 December 2018
Estimated completion31 December 2018
Sites2 locations across Egypt, India

Drugs / interventions tested

Conditions studied

Sponsor

Kasr El Aini Hospital

Who can join

18 and older, any sex, with Determining Patterns of Glaucoma in Glaucoma Sub-specialty Clinics in Two Countries: Egypt and India. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, we are aiming to identify the patterns of glaucoma observed and treated at Glaucoma Subspecialty Clinics of Kasr Al-Aini Hospital, Cairo University in Cairo, Egypt and corresponding clinics in Sadguru Netra Chikitsalaya Post Graduate Institute of Ophthalmology in Mumbai, Maharashtra, India during the year 2018. We are hoping that this study would provide an update on current statistics available on Indian population as well as provide novel numbers on the prevalence of glaucoma and its patterns in one of the largest tertiary care hospitals in Egypt. These results will then be compared to patterns observed in other epidemiological studies done in other countries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Kasr El Aini Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03491735.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing